Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,967 public trials 1,828 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, Not Recruiting

Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma

NCT05004064

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • The Royal Bournemouth Hospital Bournemouth, United Kingdom
  • University Hospital of Wales Cardiff, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • St. Bartholomew's Hospital London, United Kingdom
View Trial Details
Active, Not Recruiting

Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients

NCT03876769

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations
  • Children s Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • City of Hope National Medical Duarte, California, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
View all 43 locations
View Trial Details
Active, Not Recruiting

REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania

NCT06170671

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Research Site Piteşti, Argeş, Romania
  • Research Site Oradea, Bihor County, Romania
  • Research Site Cluj-Napoca, Cluj, Romania
  • Research Site Craiova, Dolj, Romania
View all 19 locations
View Trial Details
Active, Not Recruiting

Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia

NCT01841723

Conditions
Hairy Cell Leukemia, Hairy Cell Leukemia Variant, Hematologic Diseases, +11 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular Lymphoma

NCT04246086

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • Norton Cancer Institute - St. Matthews Louisville, Kentucky, United States
  • Mary Bird Perkins Cancer Ctr Baton Rouge, Louisiana, United States
View all 26 locations
View Trial Details

Related conditions